SEVERE WX : High Wind Warning View Alerts
STREAMING NOW: Watch Now

Nestle is paying $2.6 billion for a company that treats peanut allergies

Nestlé is buying the maker of a peanut allergy drug for children for $2.6 billion as it deepens its focus into health care and nutrition.The world's...

Posted: Aug 31, 2020 11:41 AM

Nestlé is buying the maker of a peanut allergy drug for children for $2.6 billion as it deepens its focus into health care and nutrition.

The world's largest food and beverage company plans to acquire Aimmune, a Brisbane, California-based biotechnology firm that earlier this year received US Food and Drug Administration approval for Palforzia, a drug designed to help children build up their immune response to peanuts, ideally lessening the occurrences and severity of a reaction.

Nestlé estimates that 240 million people globally have food allergies, with one of the most common being peanut allergy. The company, via its Nestlé Health Science division, has made investments into researching and developing food allergy-related products.

In 2016, Nestlé Health Sciences invested $112 million to develop a cow's milk allergy test. That same year, it also made its first investment in Aimmune. Since that time, Nestlé Health Sciences has invested a total of $473 million in the biotechnology firm, resulting in a 25.6% equity stake.

In recent years, Nestlé ramped up its push to focus on "nutrition, health and wellness" and made moves such as selling its US candy business — and products like Goobers chocolate-covered peanuts — to Ferrero for $2.8 billion in 2018.

Under the cash transaction, which is expected to close in the fourth quarter, Nestlé will pay $34.50 per share for Aimmune, nearly a 175% premium to the $12.60 closing stock price on Friday.

Nestlé's offer comes at a good time for Aimmune, which paused the commercial launch of Palforzia because of Covid-19's disruptions in health care, Kennen MacKay, an RBC Capital Markets analyst, wrote in a research note Monday. The bid from Nestlé is a "near best-case resolution" to Aimmune's challenges, he wrote.

MacKay estimates that Palforzia has a market potential north of $1.8 billion in global sales.

California Coronavirus Cases

Data is updated nightly.

Cases: 2988326

Reported Deaths: 33589
CountyCasesDeaths
Los Angeles101466213848
San Bernardino2512131560
Riverside2394122517
San Diego2117872103
Orange2108132367
Santa Clara926251065
Kern84644565
Fresno81294932
Sacramento791221080
Alameda66583757
Ventura60368412
San Joaquin56642748
Contra Costa51573446
Stanislaus42337739
Tulare40655501
Monterey35418250
San Mateo31805294
San Francisco28853254
Imperial25140463
Solano24732105
Santa Barbara24149231
Sonoma23607234
Merced23492296
Kings19125133
Placer16995173
San Luis Obispo15466128
Madera13193130
Santa Cruz12026113
Marin11482153
Yolo10406131
Shasta9594117
Butte9359121
El Dorado757544
Sutter756077
Napa735639
Lassen509413
San Benito488243
Yuba481827
Tehama397142
Tuolumne330438
Nevada314473
Mendocino307631
Amador298629
Lake250428
Humboldt229424
Glenn189419
Colusa16919
Calaveras159623
Siskiyou140813
Mono10834
Inyo92429
Del Norte8532
Plumas5735
Modoc3793
Mariposa3444
Trinity3024
Alpine730
Sierra700
Unassigned00
Chico
Partly Cloudy
68° wxIcon
Hi: 72° Lo: 53°
Feels Like: 68°
Oroville
Clear
69° wxIcon
Hi: 72° Lo: 60°
Feels Like: 69°
Chico
Clear
68° wxIcon
Hi: 68° Lo: 57°
Feels Like: 68°
Red Bluff
Clear
69° wxIcon
Hi: 47° Lo: 28°
Feels Like: 69°
Red Bluff
Clear
69° wxIcon
Hi: 69° Lo: 59°
Feels Like: 69°
Chico
Clear
68° wxIcon
Hi: 73° Lo: 61°
Feels Like: 68°
Very gusty winds, dry weather, and warm temperatures are ahead for your Martin Luther King Jr. Day today. We'll be very windy, but not as warm on Tuesday. Lighter winds, cooler temperatures, and the potential for wet weather will return in your extended forecast.
KHSL Severe
KHSL Radar
KHSL Temperatures

Community Events